NYCEDC Grants $1M To Quentis Therapeutics For Expansion Of LifeSci Space In Harlem

New York City Economic Development Corporation (NYCEDC) and Quentis Therapeutics (Quentis), a New York City-based biotechnology company whose first program develops immunotherapy to treat cancer, today announced the completion of the first LifeSci NYC Expansion Space Fund transaction. Continue Reading →